SpringWorks Therapeutics (SWTX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Jul11

Congressman sells SpringWorks Therapeutics stocks

16:08

Jul1

Merck Completes Acquisition of SpringWorks Therapeutics

12:41

SpringWorks Therapeutics Inc. Completes Merger, Each Share Converted to $47 in Cash

12:39

Jun26

SpringWorks Therapeutics Special Shareholders Meeting Approves Merger Agreement

20:45

Jun21

SG Americas Securities LLC Increased Holdings in SpringWorks Therapeutics

07:30

Jun20

SpringWorks Therapeutics Awaits Nirogacestat Approval in EU

12:01

Schedules & Filings

Schedules

Filings

May9

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 49.09 M, Net Income -83.19 M, EPS -1.1108

Feb20

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 61.55 M, Net Income -77.3 M, EPS -1.0392

Nov12

Earning Release(EST)

FY2024 Q3 Earning Release (USD) Revenue 49.3 M, Net Income -53.53 M, EPS -0.7208

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change